Correlation Between Mineralys Therapeutics, and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Champions Oncology, you can compare the effects of market volatilities on Mineralys Therapeutics, and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Champions Oncology.
Diversification Opportunities for Mineralys Therapeutics, and Champions Oncology
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Mineralys and Champions is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Champions Oncology go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Champions Oncology
Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 98.67 times less return on investment than Champions Oncology. But when comparing it to its historical volatility, Mineralys Therapeutics, Common is 1.06 times less risky than Champions Oncology. It trades about 0.0 of its potential returns per unit of risk. Champions Oncology is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 607.00 in Champions Oncology on November 3, 2024 and sell it today you would earn a total of 492.00 from holding Champions Oncology or generate 81.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Champions Oncology
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Champions Oncology |
Mineralys Therapeutics, and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Champions Oncology
The main advantage of trading using opposite Mineralys Therapeutics, and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.The idea behind Mineralys Therapeutics, Common and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |